Rub. You bring up a good point. Clinical trial sit
Post# of 148278
Gild has much more money to pay these guys. A good option for BARDA, rather than giving a large block grant to a couple of companies, is give 100 mil to each of the 20 most promising therapeutics, with stipulations that 85% get spent on clinical trial costs. That may avoid the chicken and egg we have here.
--the Gov wants data in order to give the company money, but the company needs money to gather the data.